Add to watchlist
Back

 

60033-01 - Lecture: Special Topics in Drug Discovery and Development 2 CP

Semester fall semester 2024
Course frequency Every fall sem.
Lecturers Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch)
Alex Odermatt (alex.odermatt@unibas.ch)
Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, Assessor)
Content Introduction to disease and medication
Examples of large pharma projects
Start-up vs big pharma
Pharmaceutical innovation
Treatment developments in neuroinflammatory diseases
Preclinical development
Clinical drug development
Role of drug agencies in drug development
New developments in oncology / in the treatment of hypercholesterolemia
Multiple approaches to tackle COVID-19
New developments in virology
Weblink Department of Pharmaceutical Sciences

 

Admission requirements This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch
Course application THE SEMINAR IS FULLY BOOKED!
Language of instruction English
Use of digital media No specific media used

 

Interval Weekday Time Room
wöchentlich Monday 10.15-12.00 Biozentrum, Seminarraum U1.191

Dates

Date Time Room
Monday 16.09.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 23.09.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 30.09.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 07.10.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 14.10.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 21.10.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 04.11.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 11.11.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 18.11.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 25.11.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 02.12.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Monday 09.12.2024 10.15-12.00 Biozentrum, Seminarraum U1.191
Modules Doctorate Pharmaceutical Sciences: Recommendations (PhD subject: Pharmaceutical Sciences)
Doctorate Toxicology: Recommendations (PhD subject: Toxicology)
Electives Master Science in Pharmacy: Recommendations (Master's Studies: Science in Pharmacy)
Module Specialisation: Medical Nanosciences (Master's Studies: Nanosciences)
Module: Clinical Drug Development: the Basis for Market Approval (Master's Studies: Drug Sciences)
Assessment format continuous assessment
Assessment details Regular attendance and presentation. More details will be communicated during the first lecture.
Assessment registration/deregistration Reg.: course registration, dereg: cancel course registration
Repeat examination no repeat examination
Scale Pass / Fail
Repeated registration as often as necessary
Responsible faculty Faculty of Science, studiendekanat-philnat@unibas.ch
Offered by Departement Pharmazeutische Wissenschaften

Back